However, animal studies have shown that taking semaglutide during pregnancy may increase the risk of birth defects, miscarriage, and delivering babies that are small for their gestational age
In Japan, during the first 6 months after the launch of sitagliptin, cases of severe hypoglycemia increased when sitagliptin was added onto a sulfonylurea, especially in elderly patients with renal insufficiency [44]
Blood sugar control, measured by hemoglobin A1c, improved more with surgery (-0.86%) than with medication (-0.23%)
This allows enough time to assess tolerance, track weight loss, and monitor side effects
The Unvarnished Truth About Peptide Storage Here's the honest answer: most research protocols that fail don't fail at the administration stagethey fail at storage
Semaglutide and Tirzepatide are injectable medications specifically developed for weight management